Search
- Jun 26
Agios on today’s phase 2 data for the pyruvate kinase activator mitapivat in sickle cell disease
Agios CEO Brian Goff on today's p2 SCD data and how he thinks maitapivat fits into the competitive landscape.
top of page
Search
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
Popular
#1. Pfizer’s CEO on Q2 earnings.
​
#2. Moderna CEO Stéphane Bancel on Moderna’s business at its R&D Day in New York
​
#3. UPenn’s Bruce Levine discusses the progress of CAR-T
​
#4. Learning about gene writing at Tessera Therapeutics
#5. Visiting Bayer’s Research and Innovation Center in Kendall Square
bottom of page